We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IFL:ASXInsignia Financial Ltd Analysis

Data as of 2026-08-09 - not real-time

$18.26

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Invesco Bloomberg Enhanced Fallen Angels ETF is priced at $18.26 and its moving averages line up in bearish order, the shorter trailing the longer. With RSI at 57.9 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $18.05 and resistance at $18.32.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 3.4%, a beta of 0.21 and a maximum drawdown of 5.0%, the drawdown profile is forgiving relative to most of the market. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 18.39
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 18.39
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Thin trading liquidity raises execution risk
  • Short-term moving averages stacked below long-term ones
  • 30-day volatility of 3.4%

Key Metrics & Analysis

Technical Analysis

TrendBearish
RSI57.9
Support$18.05
Resistance$18.32
MA 20$18.18
MA 50$18.23
MA 200$18.39
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta0.21
Volatility3.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.